- Home
- EPSN vs DTIL Comparison
EPSN vs DTIL Comparison
Compare EPSN & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EPSN | DTIL |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.1M | 128.8M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | EPSN | DTIL |
|---|---|---|
| Price | $5.61 | $5.62 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $60.00 |
| AVG Volume (30 Days) | ★ 217.8K | 180.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.35% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | N/A | ★ $1,070,000,000.00 |
| Revenue This Year | $41.35 | N/A |
| Revenue Next Year | N/A | $34.30 |
| P/E Ratio | $19.17 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.20 | $3.53 |
| 52 Week High | $8.50 | $8.82 |
Technical Indicators
Market Signals| Indicator | EPSN | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 63.03 | 73.04 |
| Support Level | $5.33 | $4.50 |
| Resistance Level | $6.49 | $5.80 |
| Average True Range (ATR) | 0.20 | 0.36 |
| MACD | 0.04 | 0.16 |
| Stochastic Oscillator | 71.75 | 79.86 |
Price Performance
Historical ComparisonAbout EPSN Epsilon Energy Ltd.
Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.